Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06417645
PHASE4

Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model

Sponsor: Universidad del Desarrollo

View on ClinicalTrials.gov

Summary

in healthy patients undergoing elective surgery, after a very slow induction, using Eleveld's kinetics as a reference, after loss of consciousness (LOC) and intubation, proceed to infuse propofol until 1% burst suppression ratio is obtained. Then return to the LOC concentration. The BISindex predicted by the model and the real one will be evaluated. The evolution of spectral density frequencies over time will also be evaluated.

Official title: the BIS Index Response is Poorly Described by Propofol Effect Site Eleveld's Model After Applying a Perturbation

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2013-09-01

Completion Date

2024-09-15

Last Updated

2024-05-16

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

fixed propofol infusion 15 mg/kg/h until 1% BSR (burst suppression ratio)

after a slow induction with propofol to loss of consiousness (LOC), we proceed to give remifentanil TCI and rocuronium and intubate the patient. After 5 min we infuse 15 mg/kg/h until 1%BSR observe in the BIS monitor. Then we reduce the TCI LOC predicted concentration.

Locations (1)

Hospital Base san José de Osorno

Osorno, Chile